Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Global Drug Delivery Devices Market, By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022
Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.
The Global Drug Delivery Devices Market have been segmented On the basis of product the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is segmented into solid drug, semi-solid drug and liquid drug. The Injectable drug delivery segment is further segmented into devices and formulations. Pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. Topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others.
Based on end-users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. Based on distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
The global drug delivery devices market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. The report includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.
Major Players Operating in this market:
Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.
The Global Drug Delivery Devices Market have been segmented On the basis of product the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is segmented into solid drug, semi-solid drug and liquid drug. The Injectable drug delivery segment is further segmented into devices and formulations. Pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. Topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others.
Based on end-users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. Based on distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
The global drug delivery devices market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. The report includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.
Major Players Operating in this market:
Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
